005 Topical photodynamic therapy in dermatology – 3 years experience at Beaumont Hospital

S. Collins, S. Ahmadi, G. Murphy
{"title":"005 Topical photodynamic therapy in dermatology – 3 years experience at Beaumont Hospital","authors":"S. Collins, S. Ahmadi, G. Murphy","doi":"10.1034/J.1600-0781.2002.180208_5.X","DOIUrl":null,"url":null,"abstract":"Topical photodynamic therapy (PDT) involves selective photosensitization of a target tissue by means of a topical agent, which is then activated by light to effect an oxygen dependent cytotoxic reaction. Premalignant and malignant skin conditions including actinic keratosis, squamous cell carcinoma in situ (Bowen's disease), and superficial basal cell carcinoma (BCC) have been effectively treated with PDT. A number of studies support the use of topical PDT in the treatment of acne, warts, psoriasis and T-cell lymphoma. There are many case reports and small series, with varying results, in a wide variety of other non-malignant applications. \n \n \n \nWe report our experience of topical PDT over a 3 year period. We selected patients to participate in an open study of ALA-PDT on the basis of failure of, or unsuitability for conventional therapy. One hundred and ten patients participated in the study, with a mean age of 73 years. One hundred and twenty-nine lesions were treated, which consisted of 95 lesions of Bowen's disease, 21 superficial BCC's, nine patients with multiple actinic keratosis and four with porokeratosis. Patients were assessed at 3, 6 and 12 month intervals. \n \n \n \nClearance and recurrence rules, adverse events and patient preference (where lesions had been treated previously) were recorded, Clearance rates for actinic keratosis, Bowen's disease and BCC were 87.5%, 84%, and 57%, respectively. Seventy-four percent of patients had a single treatment. Fourteen percent had two, and the remainder had up to four treatements in total. \n \n \n \nThough topical PDT has not proven to be superior to conventional methods, it is well tolerated with excellent cosmetic results. It is of particular value in the treatment of large lesions, in those with poorly vascularised skin, and in areas of diffuse actinic damage. Careful patient selection, prior debulking of lesions, and newer more selective agents with enhanced penetration, promise to further improve outcome.","PeriodicalId":20104,"journal":{"name":"Photodermatology, Photoimmunology and Photomedicine","volume":"33 1","pages":"104-104"},"PeriodicalIF":0.0000,"publicationDate":"2002-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodermatology, Photoimmunology and Photomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1034/J.1600-0781.2002.180208_5.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Topical photodynamic therapy (PDT) involves selective photosensitization of a target tissue by means of a topical agent, which is then activated by light to effect an oxygen dependent cytotoxic reaction. Premalignant and malignant skin conditions including actinic keratosis, squamous cell carcinoma in situ (Bowen's disease), and superficial basal cell carcinoma (BCC) have been effectively treated with PDT. A number of studies support the use of topical PDT in the treatment of acne, warts, psoriasis and T-cell lymphoma. There are many case reports and small series, with varying results, in a wide variety of other non-malignant applications. We report our experience of topical PDT over a 3 year period. We selected patients to participate in an open study of ALA-PDT on the basis of failure of, or unsuitability for conventional therapy. One hundred and ten patients participated in the study, with a mean age of 73 years. One hundred and twenty-nine lesions were treated, which consisted of 95 lesions of Bowen's disease, 21 superficial BCC's, nine patients with multiple actinic keratosis and four with porokeratosis. Patients were assessed at 3, 6 and 12 month intervals. Clearance and recurrence rules, adverse events and patient preference (where lesions had been treated previously) were recorded, Clearance rates for actinic keratosis, Bowen's disease and BCC were 87.5%, 84%, and 57%, respectively. Seventy-four percent of patients had a single treatment. Fourteen percent had two, and the remainder had up to four treatements in total. Though topical PDT has not proven to be superior to conventional methods, it is well tolerated with excellent cosmetic results. It is of particular value in the treatment of large lesions, in those with poorly vascularised skin, and in areas of diffuse actinic damage. Careful patient selection, prior debulking of lesions, and newer more selective agents with enhanced penetration, promise to further improve outcome.
005皮肤病学局部光动力疗法-在博蒙特医院有3年经验
局部光动力疗法(PDT)涉及通过局部药物对目标组织进行选择性光敏化,然后用光激活以影响氧依赖的细胞毒性反应。包括光化性角化病、原位鳞状细胞癌(Bowen氏病)和浅表基底细胞癌(BCC)在内的癌前和恶性皮肤状况已被PDT有效治疗。许多研究支持使用局部PDT治疗痤疮,疣,牛皮癣和t细胞淋巴瘤。有许多病例报告和小系列,不同的结果,在各种各样的其他非恶性应用。我们报告我们的经验局部PDT超过3年期间。我们在常规治疗失败或不适合的基础上选择患者参加ALA-PDT的开放研究。110名患者参与了这项研究,平均年龄为73岁。共治疗了129例病变,其中Bowen病95例,浅表性BCC 21例,多发性光化性角化病9例,多孔性角化病4例。每隔3个月、6个月和12个月对患者进行评估。记录了清除率和复发规则,不良事件和患者偏好(病变以前接受过治疗),光化性角化病,Bowen病和BCC的清除率分别为87.5%,84%和57%。74%的患者接受了一次治疗。14%的人接受了两次治疗,其余的人总共接受了四次治疗。虽然局部PDT尚未被证明优于传统方法,但它具有良好的耐受性和良好的美容效果。它在治疗大病变,血管化不良的皮肤和弥漫性光化损伤的区域具有特别的价值。仔细的患者选择,事先的病变减积,以及更新的更具选择性的药物,增强穿透性,有望进一步改善结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信